TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1

Cancer Letters

Volumn 298, Issue 1, 2010, Pages 107-118

  Ganapathy, Anu ^a   Paterson, Ian C ^a   Prime, Stephen S ^a   Eveson, John W ^a   Pring, Miranda ^a   Price, Nicky ^a   Threadgold, Suzy P ^a   Davies, Maria ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Carcinogenesis; Id1; Keratinocyte; Squamous cell carcinoma; TGF

Indexed keywords

COMPLEMENTARY DNA; INHIBITOR OF DIFFERENTIATION 1; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; IDB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; METASTASIS INHIBITION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, SQUAMOUS CELL; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; SKIN NEOPLASMS; UPREGULATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MICE; MICE, NUDE; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

MUS;

EID: 77956893106     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.06.008     Document Type: Article

References (54)

1. Massagué J. TGF-β in Cancer. Cell 2008, 134:215-230.
2. Pardali K., Moustakas A. Actions of TGF-beta as tumour suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta 2007, 1775:21-62.
3. Wakefield L.M., Roberts A.B. TGF-β signalling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 2002, 12:22-29.
4. Tang B., Vu M., Booker T., Santner S.J., Miller F.R., Anver M.R., Wakefield L.M. TGF-β switches from tumour suppressor to prometatatic factor in a model of breast cancer progression. J. Clin. Invest. 2003, 112:1116-1124.
5. Tian F., DaCosta Byfield S., Parks W.T., Yoo S., Felici A., Tang B., Piek E., Wakefield L.M., Roberts A.B. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res. 2003, 63:8284-8492.
6. Yu Q., Stamenkovic I. Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumour cell survival. Clin. Exp. Metastasis 2004, 21:235-242.
7. Biswas S., Guix M., Rinehart C., Dugger T.C., Chytil A., Moses H.L., Freeman M.L., Arteaga C.L. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J. Clin. Invest. 2007, 117:1305-1313.
8. Nam J.S., Terabe M., Mamura M., Kang M.J., Chae H., Stuelten C., Kohn E., Tang B., Sabzevari H., Anver M.R., Lawrence S., Danielpour D., Lonning S., Berzofsky J.A., Wakefield L.M. An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res. 2008, 68:3835-3843.
9. Wrzesinski S.H., Wan Y.Y., Flavell R.A. Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin. Cancer Res. 2007, 13:5262-5270.
10. Massagué J., Gomis R.R. The logic of TGF-beta signalling. Febs Lett. 2006, 580:2811-2820.
11. Tu W.H., Thomas T.Z., Masumori N., Bhowmick N.A., Gorska A.E., Shyr Y., Kasper S., Case T., Roberts R.L., Shappell S.B., Moses H.L., Matusik R.J. The loss of TGF-beta signaling promotes prostate cancer metastasis. Neoplasia 2003, 5:267-277.
12. Cherpelis B.S., Marcusen C., Lang P.G. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol. Surg. 2002, 28:268-273.
13. Weinberg A.S., Ogle C.A., Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol. Surg. 2007, 33:885-899.
14. Cui W., Fowlis D.J., Bryson S., Duffie E., Ireland H., Balmain A., Akhurst R.J. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996, 86:531-542.
15. Portella G., Cumming S.A., Liddell J., Cui W., Ireland H., Akhurst R.J., Balmain A. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 1998, 9:393-404.
16. Davies M., Prime S.S., Stone A.M., Huntley S.P., Eveson J.W., Paterson I.C. Endogenous TGF-beta1 inhibits the growth and metastatic dissemination of rat oral carcinoma cell lines but enhances local bone resorption. J. Oral Pathol. Med. 2000, 29:232-240.
17. Paterson I.C., Davies M., Stone A., Huntley S., Smith E., Pring M., Eveson J.W., Robinson C.M., Parkinson E.K., Prime S.S. TGFbeta1 acts as a tumour suppressor of human malignant keratinocytes independently of Smad4 expression and ligand induced G(1) arrest. Oncogene 2002, 21:1616-1624.
18. Thavaraj S., Paterson I.C., Hague A., Prime S.S. Over-expression of TGF-beta1 in Smad4-deficient human oral carcinoma cells causes tumour regression in vivo by mechanisms that sensitize cells to apoptosis. J. Pathol. Med. 2005, 205:14-20.
19. Fusenig N.E., Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumour progression of human skin keratinocytes. Mol. Carcinogen. 1998, 23:144-158.
20. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell. Biochem. 2005, 95:918-931.
21. Paterson I.C., Matthews J.B., Huntley S., Robinson C.M., Fahey M., Parkinson E.K., Prime S.S. Decreased expression of TGF-beta cell surface receptors during progression of human squamous cell carcinoma. J. Pathol. 2001, 193:458-467.
22. Choy L., Skillington J., Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 2000, 149:667-682.
23. Davies M., Prime S.S., Stone A.M., Heung Y.L.H., Huntley S., Matthews J.B., Eveson J.W., Paterson I.C. Overexpression of autocrine TGF-ß1 suppresses the growth of spindle epithelial cells in vitro and in vivo in the rat 4-NQO model of oral carcinogenesis. Int. J. Cancer 1997, 73:68-74.
24. Smith L.P., Thomas G.R. Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations. Part A. Chemically-induced de novo cancer, syngeneic animal models of HNSCC, animal models of transplanted xenogeneic human tumors. Int. J. Cancer 2006, 118:2111-2122.
25. Schmierer B., Hill C. TGF-β-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 2007, 8:970-982.
26. Kang Y., Chen C.R., Massagué J. A self-enabling TGF-β response coupled to stress signalling. Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 2003, 11:915-926.
27. Norton J.D. Id helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 2000, 113:3897-3905.
28. Nishimine M., Nakamura M., Mishima K., Kishi M., Kirita T., Sugimura M., Konishi N. Id proteins are overexpressed in human oral squamous cell carcinomas. J. Oral. Pathol. Med. 2003, 32:350-357.
29. Akhurst R.J., Derynck R. TGF-beta signaling in cancer-a double-edged sword. Trends Cell Biol. 2001, 11:S44-S51.
30. Oft M., Akhurst R.J., Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 2002, 4:487-494.
31. Oft M., Heider K.H., Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 1998, 8:1243-1252.
32. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massagué J., Mundy G.R., Guise T.A. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 1999, 103:197-206.
33. Han G., Lu S.L., Li A.G., He W., Corless C.L., Kulesz-Martin M., Wang X.J. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J. Clin. Invest. 2005, 115:1714-1723.
34. Fahey M.S., Paterson I.C., Stone A., Collier A.J., Heung Y.L.H., Davies M., Patel V., Parkinson E.K., Prime S.S. Dysregulation of autocrine TGF-β isoform production and ligand responses in tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts. Brit. J. Cancer 1996, 74:1074-1080.
35. Mueller M.M., Peter W., Mappes M., Huelsen A., Steinbauer H., Boukamp P., Vaccariello M., Garlick J., Fusenig N.E. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am. J. Pathol. 2001, 159:1567-1579.
36. Amendt C., Schirmacher P., Weber H., Blessing M. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 1998, 17:25-34.
37. Go C., Li P., Wang X.J. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Cancer Res. 1999, 59:2861-2868.
38. Davies M., Paterson I.C., Ganapathy A., Prime S.S. Cell death induced by N-(4-hydroxyphenyl)retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma. Int. J. Cancer 2006, 119:2803-2811.
39. Tobin S.W., Douville K., Benbow U., Brinckerhoff C.E., Memoli V.A., Arrick B.A. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Oncogene 2002, 21:108-118.
40. Siegel P.M., Shu W., Cardiff R.D., Muller W.J., Massagué J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 2003, 100:8430-8435.
41. Bierie B., Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 2006, 6:506-520.
42. Forrester E., Chytil A., Bierie B., Aakre M., Gorska A.E., Sharif-Afshar A.R., Muller W.J., Moses H.L. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 2005, 65:2296-2302.
43. Lu S.L., Herrington H., Reh D., Weber S., Bornstein S., Wang D., Li A.G., Tang C.F., Siddiqui Y., Nord J., Andersen P., Corless C.L., Wang X.J. Loss of transforming growth factor-beta type II receptor promotes metastatic head and neck carcinoma. Genes Dev. 2006, 20:1331-1342.
44. Reddy K.B., Nabha S., Atanaskova N. Role of MAP kinase in tumour progression and invasion. Cancer Metastasis Rev. 2003, 22:395-703.
45. Sahai E., Marshall C.J. Rho-GTPases and Cancer. Nat. Rev. Cancer 2002, 2:133-142.
46. Gold L.I., Jussila T., Fusenig N.E., Stenbäck F. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis. J. Pathol. 2000, 190:579-588.
47. Cho H.R., Hong S.B., Kim Y.I., Lee J.W., Kim N.I. Differential expression of TGF-beta isoforms during differentiation of HaCaT human keratinocyte cells: implication for the separate role in epidermal differentiation. J. Korean Med. Sci. 2004, 19:853-858.
48. Mincione G., Di Marcantonio M.C., Artese L., Vianale G., Piccirelli A., Piccirilli M., Perrotti V., Rubini C., Piattelli A., Muraro R. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas. Int. J. Oncol. 2008, 32:323-331.
49. Tang B., Yoo N., Vu M., Mamura M., Nam J.S., Ooshima A., Du Z., Desprez P.Y., Anver M.R., Michalowska A.M., Shih J., Parks W.T., Wakefield L.M. Transforming growth factor-ß can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast xenograft model. Cancer Res. 2007, 67:8643-8652.
50. Breuninger H., Black B., Rassner G. Microstaging of squamous cell carcinomas. Am. J. Clin. Pathol. 1990, 94:624-627.
51. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
52. Minn A.J., Gupta G.P., Padua D., Bos P., Nguyen D.X., Nuyten D., Kreike B., Zhang Y., Wang Y., Ishwaran H., Foekens J.A., van de Vijver M., Massague J. Lung metastasis genes couple breast tumour size and metastatic spread. Proc. Natl. Acad. Sci. USA 2007, 104:6740-6745.
53. Perk J., Gil-Bazo I., Chin Y., de Candia P., Chen J.J., Zhao Y., Chao S., Cheong W., Ke Y., Al-Ahmadie H., Gerald W.L., Brogi R., Benezra E. Reassessment of Id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-Id1 antibody. Cancer Res. 2006, 66:10870-10877.
54. Liang Y.Y., Brunicardin F.C., Lin X. Smad3 mediates immediate early induction of Id1 by TGF-β. Cell Res. 2009, 19:140-148.